Loading...

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:12:58

Raymond James Biotech Innovation Symposium: Dyne's...

BiotechTV - News ·

2026/04/14

He describes both the biomarker and functional benefits seen in the December data for the company's next-generation exon 51 skipping therapy.

en-us

00:08:18

Raymond James Biotech Innovation Summit: Checking in...

BiotechTV - News ·

2026/04/14

He reminds us of the unmet need for this type of therapy and discusses the planning that Vera has been doing ahead of the decision date.

en-us

00:07:54

Raymond James Biotech Innovation Symposium: Akebia's...

BiotechTV - News ·

2026/04/14

He describes physician, patient, and payor feedback from this closely watched launch. Plus, praliciguat, and why Akebia bought a targeted complement inhibitor from Q32 Bio.

en-us

00:11:46

Raymond James Biotech Innovation Symposium: Wave Life...

BiotechTV - News ·

2026/04/14

He discusses the INHBE data and the market reaction to it, which he believes is due to misconceptions about the patient population, and the next steps for this program. Plus, an AATD presentation that will happen next month at American Thoracic Society.

en-us

00:06:32

Raymond James Biotech Innovation Symposium: Tectonic...

BiotechTV - News ·

2026/04/14

CEO Alice Reicin walks us through recent data and guides for what is next in this patient population. Plus, an upcoming healthily volunteer readout for a HHT program and how it might translate to patients in future trials.

en-us

00:06:05

Raymond James Biotech Innovation Symposium: Eupraxia...

BiotechTV - News ·

2026/04/14

CEO James Helliwell describes Eupraxia's platform and how it differs from other extended release technologies. Plus, Eosinophilic Esophagitis, and how the company thinks about other uses.

en-us

00:07:07

Raymond James Biotech Innovation Symposium: Septerna...

BiotechTV - News ·

2026/04/14

Co-Founder and CEO Jeffrey Finer describes how Septerna is able to screen for GPCR targets in ways that have not previously been possible. Plus, an overview of programs targeting MRGPRX2, PTH1R, and a collaboration with Novo on obesity.

en-us

00:06:52

Raymond James Biotech Innovation Symposium: Raymond...

BiotechTV - News ·

2026/04/14

He discusses Tyra, Sionna, Alumis, Nuvalent, and Monopar.

en-us

00:06:51

Harbinger Health is announcing its emphasis on a new...

BiotechTV - News ·

2026/04/14

CEO Ajit Singh describes the idea behind the new products, and highlights that $100M has been raised to fund the development of them.

en-us

00:13:21

Spyre Therapeutics announced today that SPY001, an...

BiotechTV - News ·

2026/04/13

CEO Cameron Turtle walks us through the data, shares his opinion on its translatability to part B of the current study, and tells us what else is ahead for Spyre.

en-us

00:11:19

Alloy Therapeutics announced a deal with Biogen today...

BiotechTV - News ·

2026/04/08

He discusses the Biogen deal, and how it is a sign of increased activity Alloy sees in their genetic medicines business. Plus, monoclonals vs multispecifics, and the state of discovery work today.

en-us

00:22:44

The new CEO of Stoke Therapeutics, Ian Smith,...

BiotechTV - News ·

2026/04/08

He describes how Stoke aims to up-regulate healthy genes in cases where diseases are caused by autosomal dominant haploinsufficiencies, like Dravet. He discusses the phase 1/2 data, a phase 3 that is scheduled to read out in 2027, and the regulatory history of the program.

en-us

00:13:09

Iambic's CEO Tom Miller discusses the company's...

BiotechTV - News ·

2026/04/07

He describes the multiple variables that factor in to designing new medicines with AI, how Iambic's platform has allowed it to shorten the time to get a medicine into the clinic versus traditional discovery work, and how he thinks AI will augment the work of human scientists.

en-us

00:12:56

Already this year Chai Discovery has raised a $130M...

BiotechTV - News ·

2026/04/06

He explains how Chai-2 works, and how it compares to other antibody building / binding AI models.

en-us

00:09:02

CellCentric has kicked off dosing of its first...

BiotechTV - News ·

2026/03/31

The first patient was dosed in DOMMINO-1, a Phase 2 open-label, single-arm study enrolling 100 adult patients across clinical sites in the UK and U.S.. It could potentially offer an accelerated approval opportunity if it reaches a high enough response rate.

en-us

00:13:34

Coya Therapeutics' CEO Arun Swaminathan discusses the...

BiotechTV - News ·

2026/03/27

He describes the science behind Coya's combination therapies, and programs targeting ALS (currently in a phase 2 study), FTD, and Alzheimer's.

en-us

00:18:58

RBC Biotech Analyst Leo Timashev shares his take on...

BiotechTV - News ·

2026/03/27

He discusses Insmed, IDEAYA, Bicycle, Compass Pathways, Revolution Medicines, Cytokinetics, and CG Oncology

en-us

00:22:13

Solid Biosciences CEO Bo Cumo discusses recent DMD...

BiotechTV - News ·

2026/03/25

He describes data presented at the Muscular Dystophy Association Annual Meeting which showed biopsy and safety data for 20 patients who have been followed for 90 days and 3 who are out to a year. Plus, explaining the three FDA meetings that are key ffor the company.

en-us

00:06:57

Christian Tidona's BioMed X and Michal Preminger are...

BiotechTV - News ·

2026/03/25

Michal Preminger will lead BioMed X Venture labs as CEO, and it will partner with pharma, foundations, and VCs to build mission driven companies.

en-us

00:10:23

Apogee Therapeutics' CEO Michael Henderson discusses...

BiotechTV - News ·

2026/03/23

He discusses the the data and how he compares it to Dupixent and other medicines on the market, how translatable the data might be to a phase 3 that will be up and running later this year, and what other data the company will have in the near future.

en-us

485 results

Similar Podcasts

Planetterrian Daily

Patrick · Nerra Network

New Books in Science, Technology, and Society

New Books Network

Scifi Friday

Radio Memories Network

The Bio Report

Levine Media Group

Waterlines: How Water Shapes Our World

jaywen